Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21‐gene recurrence score: A National Cancer Database analysis-Reference-Cited by-同舟云学术

Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21‐gene recurrence score: A National Cancer Database analysis

Published:2022-02-09 Issue:9 Volume:128 Page:1738-1747
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Weiser Roi¹^ORCID,Polychronopoulou Efstathia²^ORCID,Hatch Sandra S.³⁴,Haque Waqar⁵,Ghani Hafiz A.¹^ORCID,He Jing⁶,Kuo Yong‐fang²,Gradishar William J.⁷,Klimberg V. Suzanne¹⁸

Affiliation:

1. Department of Surgery University of Texas Medical Branch Galveston Texas

2. Department of Preventive Medicine and Population Health Office of Biostatistics University of Texas Medical Branch Galveston Texas

3. Department of Radiation Oncology University of Texas Medical Branch Galveston Texas

4. Deptartment of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston Texas

5. Department of Radiation Oncology Houston Methodist Hospital Houston Texas

6. Department of Pathology University of Texas Medical Branch Galveston Texas

7. Department of Medicine and Robert H. Lurie Comprehensive Cancer Center Feinberg School of Medicine Northwestern University Chicago Illinois

8. Department of Breast Surgical Oncology The University of Texas MD Anderson Cancer Center Houston Texas

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34127

Reference33 articles.

1. Invasive lobular carcinoma of the breast: the increasing importance of this special subtype

2. Invasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage disease

3. Transcriptomic and genomic features of invasive lobular breast cancer

4. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

5. Invasive lobular breast cancer and its variants: How special are they for systemic therapy decisions?

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Invasive lobular carcinoma of the breast; clinicopathologic profile and response to neoadjuvant chemotherapy over a 15-year period;The Breast;2024-08

2. Tailoring neoadjuvant systemic therapy in breast cancer: “The advent of a personalized approach”—The Breast‐Gynecological and Immuno‐Oncology International Cancer Conference (BGICC) consensus and recommendations;Cancer;2024-07-10

3. Selecting postoperative adjuvant systemic therapy for early‐stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assays;Journal of Surgical Oncology;2024-06-24

4. Deciphering the Clinical Behaviour of Invasive Lobular Carcinoma of the Breast Defines an Aggressive Subtype;Cancers;2024-05-16

5. Adjuvant Chemotherapy in Premenopausal Patients With Hormone-Positive Breast Cancer With a Recurrence Score of 16-25: A Retrospective Analysis Using the National Cancer Database;JCO Precision Oncology;2024-03